U.S. flag

An official website of the United States government

NM_001370658.1(BTD):c.-17_-17+3del AND Biotinidase deficiency

Germline classification:
Likely pathogenic (2 submissions)
Last evaluated:
Feb 9, 2022
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000667343.3

Allele description [Variation Report for NM_001370658.1(BTD):c.-17_-17+3del]

NM_001370658.1(BTD):c.-17_-17+3del

Gene:
BTD:biotinidase [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
3p25.1
Genomic location:
Preferred name:
NM_001370658.1(BTD):c.-17_-17+3del
HGVS:
  • NC_000003.12:g.15601894_15601897del
  • NG_008019.3:g.5544_5547del
  • NG_098817.1:g.521_524del
  • NM_001281724.3:c.-205_-205+3del
  • NM_001281726.3:c.-17_-17+3del
  • NM_001323582.2:c.-293_-293+3del
  • NM_001370658.1:c.-17_-17+3delMANE SELECT
  • NM_001370752.1:c.-17_-17+3del
  • NM_001370753.1:c.-17_-17+3del
  • NM_001407365.1:c.-17+247_-17+250del
  • NM_001407366.1:c.-582_-582+3del
  • NM_001407369.1:c.-568_-568+3del
  • NM_001407370.1:c.-569+124_-569+127del
  • NM_001407371.1:c.-743+124_-743+127del
  • NM_001407372.1:c.-174_-174+3del
  • NM_001407373.1:c.-136_-136+3del
  • NM_001407374.1:c.-191_-191+3del
  • NM_001407378.1:c.-394_-394+3del
  • NM_001407380.1:c.-17_-17+3del
  • NM_001407384.1:c.-293_-293+3del
  • NM_001407390.1:c.-191_-191+3del
  • NM_001407394.1:c.-293+124_-293+127del
  • NM_001407395.1:c.-132_-132+3del
  • NM_001407398.1:c.-17_-17+3del
  • NM_001407400.1:c.-17_-17+3del
  • NC_000003.11:g.15643401_15643404del
  • NG_008019.2:g.5543_5546del
  • NM_001370658.1:c.-17_-17+3delGGTAMANE SELECT
Links:
dbSNP: rs1050514843
NCBI 1000 Genomes Browser:
rs1050514843
Molecular consequence:
  • NM_001407365.1:c.-17+247_-17+250del - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001407370.1:c.-569+124_-569+127del - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001407371.1:c.-743+124_-743+127del - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001407394.1:c.-293+124_-293+127del - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001281724.3:c.-205_-205+3del - splice donor variant - [Sequence Ontology: SO:0001575]
  • NM_001281726.3:c.-17_-17+3del - splice donor variant - [Sequence Ontology: SO:0001575]
  • NM_001323582.2:c.-293_-293+3del - splice donor variant - [Sequence Ontology: SO:0001575]
  • NM_001370658.1:c.-17_-17+3del - splice donor variant - [Sequence Ontology: SO:0001575]
  • NM_001370752.1:c.-17_-17+3del - splice donor variant - [Sequence Ontology: SO:0001575]
  • NM_001370753.1:c.-17_-17+3del - splice donor variant - [Sequence Ontology: SO:0001575]
  • NM_001407366.1:c.-582_-582+3del - splice donor variant - [Sequence Ontology: SO:0001575]
  • NM_001407369.1:c.-568_-568+3del - splice donor variant - [Sequence Ontology: SO:0001575]
  • NM_001407372.1:c.-174_-174+3del - splice donor variant - [Sequence Ontology: SO:0001575]
  • NM_001407373.1:c.-136_-136+3del - splice donor variant - [Sequence Ontology: SO:0001575]
  • NM_001407374.1:c.-191_-191+3del - splice donor variant - [Sequence Ontology: SO:0001575]
  • NM_001407378.1:c.-394_-394+3del - splice donor variant - [Sequence Ontology: SO:0001575]
  • NM_001407380.1:c.-17_-17+3del - splice donor variant - [Sequence Ontology: SO:0001575]
  • NM_001407384.1:c.-293_-293+3del - splice donor variant - [Sequence Ontology: SO:0001575]
  • NM_001407390.1:c.-191_-191+3del - splice donor variant - [Sequence Ontology: SO:0001575]
  • NM_001407395.1:c.-132_-132+3del - splice donor variant - [Sequence Ontology: SO:0001575]
  • NM_001407398.1:c.-17_-17+3del - splice donor variant - [Sequence Ontology: SO:0001575]
  • NM_001407400.1:c.-17_-17+3del - splice donor variant - [Sequence Ontology: SO:0001575]

Condition(s)

Name:
Biotinidase deficiency
Synonyms:
BTD deficiency; Late-onset biotin-responsive multiple carboxylase deficiency; Biotin deficiency
Identifiers:
MONDO: MONDO:0009665; MedGen: C0220754; Orphanet: 79241; OMIM: 253260

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000791776Counsyl
criteria provided, single submitter

(Counsyl Autosomal Recessive and X-Linked Classification Criteria (2018))
Likely pathogenic
(May 23, 2017)
unknownclinical testing

Citation Link,

SCV002103645Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Likely pathogenic
(Feb 9, 2022)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Counsyl, SCV000791776.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV002103645.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

Variant summary: BTD c.-17_-17+3delGGTA is located at the splice-site region in the non-coding exon 1, upstream of the initiation codon, and is predicted to abolish the canonical 5' splice donor site (Alamut). These predictions have yet to be confirmed by functional studies. The variant was absent in 249988 control chromosomes (gnomAD). To our knowledge, no occurrence of c.-17_-17+3delGGTA in individuals affected with Biotinidase Deficiency and no experimental evidence demonstrating its impact on protein function have been reported. While exon 1 is absent in most tissues in the GTEx database, and is a non-coding exon in the transcript utalized for this classification, there is evidence that exon 1 remains an important region of the gene. Another variant which impacts the same splice-site, c.-17+1G>A, has been reported a patient with partial Biotinidase Deficiency (Murry_2018) and is reported via ClinVar as likely pathogenic. Additionally, a 107-kb contiguous deletion of three genes in homozygosity, including exon 1 of the BTD gene, has been reported in a child whose symptoms were apparently solely attributable to the BTD gene and improved with biotin supplementation (Senanayake_2015). The authors of this study concluded that deletion of exon 1 results in the inability to synthesize the active enzyme product, as exon 1 contains the initiation site and leader signal sequence of the enzyme, supporting a critical role for this exon, with the caveat that a deletion of the region may have a different impact than a variant affecting splicing (Senanayake et al. 2015). One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 and classified the variant as likely pathogenic. Based on the evidence outlined above, the variant was classified as likely pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Mar 26, 2023